Can I Take Calcium with Avodart (Dutasteride)?

How Dutasteride Is Absorbed and Why That Matters

Dutasteride (Avodart, 0.5 mg once daily) is a dual 5-alpha reductase inhibitor approved by the FDA for benign prostatic hyperplasia and used off-label for androgenetic alopecia. Its absorption profile is dominated by high lipophilicity, not ionic chemistry. Peak plasma concentration arrives roughly 1 to 3 hours after an oral dose, and bioavailability sits at approximately 60% regardless of food. [1]

The Chelation Mechanism Does Not Apply Here

Calcium interferes with certain drugs through chelation: the calcium ion forms an insoluble complex with the drug molecule in the gut, preventing absorption. This is the reason men taking thyroid hormone or certain antibiotics are told to separate doses from calcium by at least 2 hours.

Dutasteride is a synthetic azasteroid with no carboxylate, phosphate, or tetracycline-like binding groups that calcium would chelate. Published interaction databases, including the Natural Medicines database and the FDA's drug interaction table for Avodart, list no chelation concern between calcium and dutasteride. [2]

CYP3A4 and What Actually Does Interact with Dutasteride

Dutasteride is metabolized almost entirely by CYP3A4 and CYP3A5 in the liver. Drugs or supplements that inhibit these enzymes (ketoconazole, ritonavir, clarithromycin) can raise dutasteride plasma levels; inducers (rifampicin, St. John's Wort) can lower them. [2]

Calcium, whether from food or a supplement, has no meaningful effect on CYP3A4 or CYP3A5 activity at physiological doses. The mechanism simply does not exist.

What the Pharmacokinetic Data Actually Show

No head-to-head randomized trial has specifically tested concurrent calcium supplementation in men enrolled in a dutasteride trial, because the interaction hypothesis has never been biologically plausible enough to fund such a study. The evidence base is built from:

1. Dutasteride's pharmacokinetic characterization in the FDA prescribing information. [2]
2. Calcium's known interaction mechanisms catalogued in systematic reviews of mineral-drug interactions. [3]
3. The large dutasteride outcome trials (REDUCE, CombAT), none of which excluded calcium supplementation or flagged it as a confound.

REDUCE Trial Context

The REDUCE trial (N = 6,729) evaluated dutasteride 0.5 mg daily versus placebo over 4 years for prostate cancer risk reduction. Participants were not restricted from calcium supplementation. No post-hoc analysis identified calcium use as a variable that modified dutasteride's pharmacologic effect. [4]

CombAT Trial Context

CombAT (N = 4,844) compared dutasteride alone, tamsulosin alone, and the combination over 4 years in men with BPH. Again, calcium supplementation was not a pre-specified exclusion criterion and no pharmacokinetic sub-study flagged it as relevant. [5]

The absence of any signal across two large, long-duration trials involving men of an age group (mean age mid-60s) who are commonly advised to supplement calcium is itself informative.

Calcium Safety Considerations That Do Apply to Men on Dutasteride

Even though calcium and dutasteride do not interact pharmacokinetically, calcium supplementation carries its own risk considerations that become clinically relevant for the same patient population.

Cardiovascular Signal in Supplemental Calcium

A meta-analysis published in the BMJ (Bolland et al., 2010, N = 12,000 across 11 trials) found that calcium supplementation without co-administered vitamin D was associated with a relative risk of myocardial infarction of 1.27 (95% CI 1.01 to 1.59). [6] This finding remains contested, and the U.S. Preventive Services Task Force states the evidence is insufficient to make a recommendation for or against calcium supplementation in community-dwelling adults for primary cardiovascular prevention. [7]

Men with BPH are typically older, often 55 to 80 years of age, a demographic where cardiovascular risk is already elevated. Physicians managing these men on dutasteride should discuss total daily calcium intake, including dietary sources, before recommending supplemental calcium.

Upper Tolerable Intake Level

The National Institutes of Health Office of Dietary Supplements sets the Tolerable Upper Intake Level (UL) for calcium at 2,500 mg/day for adults aged 19 to 50 and 2,000 mg/day for adults 51 and older. [3] Exceeding the UL has been associated with hypercalcemia, nephrolithiasis, and the disputed cardiovascular signal above.

A standard diet supplies roughly 700 to 900 mg of calcium daily. Adding a 1,200 mg supplement to that total pushes some men above the UL without realizing it.

Calcium and Prostate Cancer Risk

The relationship between high calcium intake and prostate cancer risk has been studied without a definitive conclusion. The Health Professionals Follow-Up Study observed a modest positive association between calcium intake above 1,500 mg/day and advanced prostate cancer, though confounding by dairy fat was acknowledged. [8] Because dutasteride is itself used in prostate cancer risk reduction strategies, clinicians should be aware of this signal when advising calcium supplementation in this population.

Calcium and Other Drugs Commonly Co-prescribed with Dutasteride

This is where calcium timing genuinely matters. Men with BPH are often older adults who take multiple medications simultaneously.

Alpha-Blockers

Tamsulosin (Flomax) and silodosin are frequently co-prescribed with dutasteride for BPH. Neither is chelation-sensitive; calcium does not impair their absorption. No dose separation is required. [5]

Levothyroxine

Hypothyroidism affects approximately 5% of the male population over age 60. If a man takes both dutasteride and levothyroxine, calcium supplementation must be timed carefully: calcium carbonate has been shown in controlled studies to reduce levothyroxine bioavailability by up to 40% when taken simultaneously. [9] Take levothyroxine on an empty stomach 60 minutes before any calcium-containing supplement.

Fluoroquinolone Antibiotics

Ciprofloxacin and levofloxacin are chelated by divalent cations including calcium, magnesium, and iron. If a short antibiotic course is prescribed while the patient is on dutasteride and a calcium supplement, the antibiotic should be taken 2 hours before or 6 hours after the calcium dose.

Bisphosphonates

Alendronate and risedronate (common in older men with osteoporosis) have strict separation rules: take on an empty stomach with plain water, 30 to 60 minutes before any food, drink, or supplement. Calcium taken simultaneously with a bisphosphonate can reduce bisphosphonate absorption by 60% or more. [3]

HealthRX Calcium Timing Framework for Men on Dutasteride

| Drug taken alongside calcium | Interaction with calcium | Recommended separation | |---|---|---| | Dutasteride 0.5 mg | None | None required | | Tamsulosin 0.4 mg | None | None required | | Levothyroxine | Absorption reduced up to 40% | Levothyroxine 60 min before calcium | | Ciprofloxacin / levofloxacin | Chelation reduces antibiotic AUC | 2 hr before or 6 hr after calcium | | Alendronate / risedronate | Chelation reduces bisphosphonate absorption by 60%+ | Bisphosphonate on empty stomach 30 to 60 min before calcium | | Silodosin | None | None required |

How to Choose the Right Calcium Supplement Form

Not all calcium supplements behave identically in the gut, and the distinction matters for absorption efficiency.

Calcium Carbonate vs. Calcium Citrate

Calcium carbonate (the most common and least expensive form) requires stomach acid for dissolution. Men who take proton pump inhibitors (PPIs) such as omeprazole, which are themselves sometimes used in older men, absorb calcium carbonate less reliably. A pharmacokinetic study showed that calcium citrate absorption was not affected by achlorhydria, whereas calcium carbonate absorption dropped significantly under low-acid conditions. [10]

If a man on dutasteride also takes a PPI, calcium citrate is the more appropriate supplement form.

Elemental Calcium Content

• Calcium carbonate: 40% elemental calcium (a 1,250 mg tablet provides 500 mg elemental calcium)
• Calcium citrate: 21% elemental calcium (a 2,380 mg tablet provides 500 mg elemental calcium)

Patients frequently confuse the tablet weight with the elemental dose. This leads to either under-supplementation or unintentional excess.

Vitamin D Co-supplementation

Vitamin D3 (cholecalciferol) enhances intestinal calcium absorption via upregulation of TRPV6 calcium channels. The USPSTF recommends against routine vitamin D supplementation for primary cancer prevention but acknowledges its role in calcium metabolism for bone health. [7] Most calcium supplements intended for bone health now include vitamin D3 at 400 to 800 IU per dose.

Dutasteride does not interact with vitamin D at any known mechanistic level.

Monitoring Recommendations for Men Taking Both

Even when two agents do not interact, a structured monitoring plan protects the patient.

PSA Monitoring on Dutasteride

Dutasteride reduces serum PSA by approximately 50% after 3 to 6 months of therapy. The FDA prescribing information specifies that a new PSA baseline should be established after 3 to 6 months, and any confirmed increase from that baseline should prompt evaluation even if the absolute PSA value remains in the normal range. [2] Calcium supplementation does not affect PSA assay results and does not interfere with this monitoring protocol.

Bone Density and Calcium Adequacy

Men on long-term dutasteride for BPH do not incur additional osteoporosis risk from the drug itself; 5-alpha reductase inhibitors do not suppress testosterone to hypogonadal levels. Baseline DEXA scanning is appropriate for men 70 and older or younger men with additional osteoporosis risk factors, independent of dutasteride use.

Serum Calcium and Kidney Function

Men taking supplemental calcium above 1,000 mg/day should have serum calcium and creatinine checked annually. Hypercalcemia is uncommon at recommended doses but can occur in men with occult hyperparathyroidism or vitamin D toxicity.

Practical Guidance: What to Tell Your Doctor

Transparency about all supplements is essential when managing a multi-drug regimen. The American Urological Association's 2021 BPH guideline states: "Clinicians should discuss lifestyle modifications including dietary changes and supplement use with patients before and during pharmacotherapy for LUTS/BPH." [11]

A direct quotation from the FDA's Avodart prescribing information: "No dose adjustment is necessary for patients with renal impairment. AVODART has not been studied in patients with severe hepatic impairment." [2] This underscores that the prescribing information addresses known interaction risks; calcium is absent from that list.

At your next appointment, bring a complete list of every supplement with the brand name, elemental dose, and timing. Specifically ask about:

• Total daily elemental calcium from food plus supplements combined
• Whether any current co-medications are chelation-sensitive
• Whether a DEXA scan is appropriate given your age and risk profile
• Cardiovascular risk in the context of supplemental calcium if you are above age 60

Men who are on dutasteride for male pattern hair loss rather than BPH follow identical guidance regarding calcium; the drug's pharmacokinetics are the same regardless of indication.

Special Populations

Men with Chronic Kidney Disease

Calcium metabolism is disrupted in CKD stages 3 to 5, where secondary hyperparathyroidism and hyperphosphatemia can coexist. Supplemental calcium in these men must be managed by a nephrologist. Dutasteride itself does not require dose adjustment for renal impairment, but calcium choices and doses are considerably more complex in this group.

Men with a History of Kidney Stones

Calcium oxalate is the most common kidney stone type. Counterintuitively, dietary calcium is protective against oxalate stones because it binds oxalate in the gut before absorption. Supplemental calcium taken apart from meals does not carry this protective effect and may increase stone risk. Men on dutasteride with a stone history should take calcium supplements with meals and keep supplemental doses at or below 500 mg per sitting.

Men on Androgen Deprivation Therapy for Prostate Cancer

Dutasteride is distinct from androgen deprivation therapy (ADT). Men on ADT (GnRH agonists/antagonists such as leuprolide or degarelix) do experience hypogonadism-related bone loss and are formally recommended by the American Urological Association and American Society of Clinical Oncology to receive calcium 1,200 mg/day plus vitamin D 800 to 1,000 IU/day. [12] This guidance does not extend to men on dutasteride alone, whose testosterone levels remain physiologically intact.